Demis Hassabis’ AI company raises $5 billion, months after he left as Google DeepMind CEO
Reported by CNBC1 source ↓
Isomorphic Labs raised a $5 billion Series C to fund AI-based drug design and development. The company says it plans to advance its therapeutic programs toward clinical trials.
Key points
- The Series C was co-led by Greenoaks and Sequoia Capital
- Andreessen Horowitz and Alphabet also invested
- Isomorphic last raised $2.1 billion in a Series B in May
Sources
Details
Isomorphic Labs said the Series C was co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz and Alphabet also investing. The company was founded by Demis Hassabis, who has led it since it spun out of DeepMind in 2021.
The company says it will use the funds to develop AI-based medicines, build biology models and advance its therapeutic programs toward clinical trials. CNBC reports Hassabis stepped back as CEO of Google DeepMind three and a half months before the funding announcement.
Written from coverage as of
Images
- CNBC
Stocks in this story
Change since open: 20 Nov to 21 Nov 2026
Last refresh